This one-and-a-half-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma by novel immunotherapies, stem cell transplantation and treatment combinations. Updates on evolving immunologically and molecular-based system therapies will be profiled and discussed.